Malaria Vaccines
Approved medicineAlso known as malaria, malaria vaccine.
Recent clinical, regulatory, research and industry developments relating to this drug.
Sickle Cell Trait Linked to Distinct Malaria Parasite Variants
Mosquitoes, malaria, and UK R&D viral disease vaccine investment
'I Really Hoped That I Had Malaria': What We Heard This Week
Dolly Parton's Health Struggles; Fauci Prosecution Stalled; Germany's Malaria Deaths
Climate Change Will Reshape Malaria Prevalence Across Africa
[Newsdesk] The Global Fund supports malaria response in DR Congo
Malaria-Causing Plasmodium in Uganda Show Rapid Spread of Drug Resistance Mutations
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes1
Journals, researchers & institutions
- Nature medicine1
- Arulanantham N1
- Blanchard TJ1
- Brown K1
- Butcher G1
- Cummings J1
- Dunachie S1
- Everaere S1
- Flanagan K1
- University of Oxford1
- RxNorm (U.S. National Library of Medicine) — drug identity
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials